Advancing Antibiotic-Resistant Microbe Combat: Nanocarrier-Based Systems in Combination Therapy Targeting Quorum...

Area of Science:

• Microbiology
• Nanotechnology
• Infectious Diseases

Background:

• Rising antibiotic resistance poses a global public health threat, necessitating new therapeutic strategies.
• Bacterial quorum sensing (QS) regulates virulence and biofilm formation, making it a key target for intervention.
• Quorum quenching (QQ) disrupts bacterial communication, reducing virulence and preventing biofilms.

Purpose of the Study:

• To review the potential of nanocarriers in disrupting bacterial quorum sensing pathways.
• To highlight nanotechnology's role in developing novel antimicrobial treatments against resistant pathogens.
• To explore nanocarrier-based strategies as alternatives to conventional antibiotics.

Main Methods:

• Review of current literature on nanocarrier applications in quorum sensing inhibition.
• Analysis of nanocarrier properties (size, surface chemistry) for targeting bacterial communication.
• Examination of nanocarrier integration into combination therapies for enhanced efficacy.

Main Results:

• Nanocarriers can effectively target various stages of the quorum sensing pathway.
• Their properties enable biofilm penetration, cell membrane disruption, and proliferation inhibition.
• Combination therapies with nanocarriers show enhanced treatment efficacy and specificity.

Conclusions:

• Nanotechnology offers a transformative approach to combating antibiotic resistance by targeting bacterial communication.
• Nanocarrier-based quorum quenching presents a promising alternative to traditional antibiotics.
• Further research is needed to address stability, safety, and clinical efficacy challenges for widespread adoption.